Hypoxia upregulates the expression of the O-linked N-acetylglucosamine containing epitope H in human ependymal cells

Pathology Research and Practice

Volumn 207, Issue 2, 2011, Pages 91-96

  Arvanitis, Leonidas D ^a   Vassiou, Katerina ^a   Kotrotsios, Anastasios ^a   Sgantzos, Markos N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Ependymal cells; Epitope H; Hypoxia; O GlcNAc

Indexed keywords

EPITOPE; EPITOPE H; N ACETYLGLUCOSAMINE; O LINKED N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BRAIN HYPOXIA; CELL ACTIVITY; CELL NUCLEUS; CHILD DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EPENDYMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; NEWBORN; PREMATURITY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; UPREGULATION;

EID: 79551575002     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.10.008     Document Type: Article

References (57)

1. Akimoto Y., Hart G.W., Wells L., Vosseller K., Yamamoto K., Munetomo E., Ohara-Imaizumi M., Nishiwaki C., Nagamatsu S., Hirano H., et al. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology 2007, 17:127-140.
2. Arvanitis D.L., Kouklis P., Mori de Moro G., Goutas N., Kittas C., Szuchet S. Immunostaining of ductal breast carcinomas with the monoclonal antibody H. Oncol. Rep. 1995, 2:991-995.
3. Arvanitis D.L., Stavridou A.I., Mori de Moro G., Szuchet S. Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res. 2001, 304:11-19.
4. Arvanitis D.L., Arvanitis L.D., Panourias I.G., Kitsoulis P., Kanavaros P. The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas. Histol. Histopathol. 2005, 20:1057-1063.
5. Arvanitis D.L., Arvanitis L.D., Panourias I.G., Kitsoulis P., Kanavaros P. Mitochondria-rich normal, metaplastic and neoplastic cells show overexpression of the epitope H recognized by the monoclonal antibody H. Pathol. Res. Pract. 2005, 201:319-324.
6. Arvanitis L.D., Koukoulis G.K., Kanavaros P. The expression of the O-linked N-acetylglucosamine containing epitope H in the gemistocytic, pilocytic and subependymal giant cell astrocytomas. Oncol. Rep. 2009, 22:521-524.
7. Boehmelt G., Wakeham A., Elia A., Sasaki T., Plyte S., Potter J., Yang Y., Tsang E., Ruland J., Iscove N.N., Dennis J.W., Mak T.W. Decreased UDP-GlcNAc levels abrogate proliferation control in Emeg32-deficient. EMBO J. 2000, 19:5092-5104.
8. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004, 287:817-833.
9. Butkinaree C., Park K., Hart G.W. O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 2010, 1800:96-106.
10. Champattanachai V., Marchase R.B., Chatham J.C. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am. J. Physiol. Cell Physiol. 2007, 292:178-187.
11. Chatham J.C., Nöt L.G., Fülöp N., Marchase R.B. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma. Shock 2008, 29:431-440.
12. Cheng X., Cole R.N., Zaia J., Hart G.W. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry 2000, 39:11609-11620.
13. Cheng X., Hart G.W. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J. Biol. Chem. 2001, 276:10570-10575.
14. Chou C.F., Smith A.J., Omary B.M. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J. Biol. Chem. 1992, 267:3901-3906.
15. Chou T.Y., Hart G.W. O-linked N-acetylglycosamine and cancer: messages from the glycosylation of c-myc. Adv. Exp. Med. Biol. 2001, 491:413-418.
16. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 2003, 278:44230-44237.
17. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Samudio I., Kladde M.P., Vyhlidal C., Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J. Biol. Chem. 1999, 274:32099-32107.
18. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 2001, 108:1341-1348.
19. Fang B., Miller M.W. Use of galactosyltransferase to assess the biological function of O-linked N-acetyl-d-glycosamine A potential role for O-GlcNAc during cell division. Exp. Cell Res. 2001, 263:243-253.
20. Filippis A., Clark S., Proietto J. Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem. J. 1997, 324:981-985.
21. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001, 50:2363-2375.
22. Gao Y., Miyazaki J., Hart G.W. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch. Biochem. Biophys. 2003, 415:155-163.
23. Guinez C., Mir A.M., Leroy Y., Cacan R., Michalski J.C., Lefebvre T. Hsp70-GlcNAc-binding activity is released by stress, proteasome inhibition, and protein misfolding. Biochem. Biophys. Res. Commun. 2007, 361:414-420.
24. Haltiwagner R.S, Busby S., Grove K. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?. Biochem. Biophys. Res. Commun. 1997, 231:237-242.
25. Hanover J.A., Krause M.W., Love D.C. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim. Biophys. Acta 2010, 1800:80-95.
26. Hart G.W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 1997, 66:315-335.
27. Havaki S., Kittas C., Marinos E., Dafni U., Sotiropoulou C., Voloudakis-Baltatzis I., Goutas N., Vassilaros S.D., Athanassiou E., Arvanitis D.L. Ultrastructural immunostaining of infiltrating ductal breast carcinomas with the monoclonal antibody H: a comparative study with cytokeratin 8. Ultrastruct. Pathol. 2003, 27:393-407.
28. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., Scholey J.W. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes 2002, 51:1146-1156.
29. Khidekel N., Ficarro S.B., Peters E.C., Hsieh-Wilson L.C. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13132-13137.
30. Kornfeld R. Studies on l-glutamine d-fructose 6-phosphate amidotransferase I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J. Biol. Chem. 1967, 242:3135-3141.
31. Lim K.H., Chang H.I. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett. 2006, 580:4645-4652.
32. Liu J., Pang Y., Chang T., Bounelis P., Chatham J.C., Marchase R.B. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J. Mol. Cell Cardiol. 2006, 40:303-312.
33. Love D.C., Hanover J.A. The hexosamine signaling pathway: deciphering the " O-GlcNAc code" Sci. STKE 2005, 312:re13.
34. Majumdar G., Wright J., Markowitz P., Martinez-Hernandez A., Raghow R., Solomon S.S. Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1. Diabetes 2004, 53:3184-3192.
35. Manzari B., Kudlow J.E., Fardin P., Morello E., Ottaviano C., Puppo M., Eva A., Varesio L. Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid. Int. J. Immunopathol. Pharmacol. 2007, 20:47-58.
36. 2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc. Am. J. Physiol. Cell Physiol. 2006, 290:57-65.
37. Patti M.E., Virkamaki A., Landaker E.J., Kahn C.R., Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 1999, 48:1562-1571.
38. Polyzos P.T., Arvanitis LD, Charchanti A, Galani V, Havaki S, Kallioras VA, Nakou M, Faros EG, Marinos E, Sgantzos MN and Kittas C: Decidualized and pre-decidualized normal endometrial stromal cells produce more O-linked N-acetylglucosamine containing epitope H than non-decidualized normal endometrial stromal cells. Histol Histopathol Vol:21,Iss:10-12,Pages:1193-1198, 2006.
39. Powell S.R., Wang P., Katzeff H., Shringarpure R., Teoh C., Khaliulin I., Das D.K., Davies K.J., Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid. Redox Signal. 2005, 7:538-546.
40. Pye J., Ardeshirpour F., McCain A., Bellinger D.A., Merricks E., Adams J., Elliott P.J., Pien C., Fischer T.H., Jr Baldwin A.S., et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:919-926.
41. Roquemore E.P., Chevrier M.R., Cotter R.J., Hart G.W. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry 1996, 35:3578-3586.
42. Sgantzos M.N., Galani V., Arvanitis L.D., Charchanti A., Psathas P., Nakou M., Havaki S., Kallioras V., Marinos E., Vamvakopoulos N.C., Kittas C. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Pathol. Res. Pract. 2007, 203:31-37.
43. Shaw P., Freeman J., Bovey R., Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 1996, 12:921-930.
44. Temsah R.M., Kawabata K., Chapman D., Dhalla N.S. Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:1461-1466.
45. Van den Steen P., Rudd P.M., Dwek R.A., Opdenakker G. Concepts and principles of O-linked glycosylation. Crit. Rev. Mol. Biol. 1998, 33:151-208.
46. Wang Z., Pandey A., Hart G.W. Dynamic interplay between O-GlcNAcylation and GSK-3-dependent phosphorylation. Mol. Cell Proteomics 2007, 6:1365-1379.
47. Wang Z., Gucek M., Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13793-137938.
48. Wells L., Gao Y., Mahoney K., Vosseler C., Chen A., Rosen A., Hart G.W. Dynamic O- glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic β-N-acetylglycosaminidase, O-GlcNAcase. J. Biol. Chem. 2002, 277:1755-1761.
49. Wells L., Whelan S.A., Hart G.W. O-GlcNAc: a regulatory post-translational modification. Biochem. Biophys. Res. Com. 2003, 302:435-441.
50. Whelan S.A., Hart G.W. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ. Res. 2003, 93:1047-1058.
51. Zachara N.E., Hart G.W. The emerging significance of O-GlcNAc in cellular regulation. Chem. Rev. 2002, 102:431-438.
52. Zachara N.E., Hart G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochem. Biophys. Acta 2004, 1673:13-28.
53. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress A survival response of mammalian cells. J. Biol. Chem. 2004, 279:30133-30142.
54. Zachara N.E., Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim. Biophys. Acta 2006, 1761:599-617.
55. Zeidan Q., Hart G.W. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell Sci. 2010, 123:13-22.
56. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003, 115:715-725.
57. Zou L.Y., Yang S., Chaudry I.H., Marchase R.B., Chatham J.C. The protective effect of glucosamine on cardiac function following trauma hemorrhage: downregulation of cardiac NF-[kappa]B signaling. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:515-523.